Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 1440 of 6372
-
AI assistant could transform kidney care in emergency rooms
Knowledge-focused Recruiting nowStudy Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, c…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New pill aims to cut COPD attacks in half
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of RSS0343 tablets in patients with COPD. The study includes 3 study periods: a 4-week screening period, a 48-week treatment period, and …
Phase 2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill could slow blindness in inherited eye disease
Disease control OngoingThis integrated Ph1/2 clinical study is to assess the safety, tolerability and pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of OCT-980 in healthy volunteers and participants with RHO-adRP.
Phase 1/2 • Sponsor: Octant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New heart surgery technique aims to prevent silent strokes
Disease control Recruiting nowTo explore surgical strategies that reduce perioperative neurologic complications in cardiovascular surgery, with the aim of improving perioperative outcomes and quality of life while reducing the socioeconomic burden. Specifically: This multicenter, randomized controlled clinic…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
VR headsets could keep ICU patients mentally clear
Prevention Recruiting nowThe purpose of this study is to evaluate whether daily exposure to immersive virtual reality (VR) can reduce the incidence of delirium in high-risk, non-intubated ICU patients. Participants will be randomized to either standard ICU care or standard care plus once-daily 15-minute …
Sponsor: Cedars-Sinai Medical Center • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Brain priming before weights: a new edge for athletes?
Knowledge-focused CompletedThis study investigated the acute and short-term effects of neuroathletic training (NAT)-integrated resistance training compared with conventional resistance training on physical and neuromuscular performance in collegiate athletes. Fifty-eight collegiate athletes completed two e…
Sponsor: Ankara Yildirim Beyazıt University • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New combo therapy aims to slow progressive MS disability
Disease control Recruiting nowThe main purpose of this study is to assess the efficacy of RO7268489 in adults with progressive multiple sclerosis (PMS) receiving ocrelizumab. After the end of the double-blind period, an open-label (OL) extension may allow eligible participants to receive open-label RO7268489.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hope for vitiligo: experimental drug aims to bring back skin color
Disease control Recruiting nowThe main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 13:01 UTC
-
One shot for two viruses? new combo vaccine enters early human testing
Vaccine Recruiting nowThis early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of its safety and how it builds protection. Healthy adults aged 65 to 85 will receive different doses of this new vaccine, a standard flu vaccine, or COVI…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jul 02, 2026 00:00 UTC
-
Could a cochlear implant help kids who are deaf in one ear?
Symptom relief Recruiting nowToday, unilateral hearing loss must be assessed and managed just as bilateral hearing loss is. It is recommended to consider the auditory difficulties caused by the loss of stereophonic hearing and to offer auditory rehabilitation as early as possible. Studies show that hearing d…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Texts and trinkets: a new way to help teens stick with HIV meds?
Disease control Not yet recruitingMany adolescents living with HIV have difficulty taking their medicine on time, which can make it less effective and affect their health. This study will test whether sending reminder text messages, combined with small rewards like school supplies, hygiene kits, or sports items, …
Sponsor: Arba Minch University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Lower-Dose drug may make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis Phase 2, single-arm, open-label study aims to evaluate the safety and efficacy of low-dose (25 mg/kg) post-transplant cyclophosphamide (PTCy) for prophylaxis of Graft-versus-Host Disease (GVHD) in patients undergoing allogeneic stem cell transplantation following reduced-int…
Phase 2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New moms with birth trauma: could writing or breathing be the key to easing PTSD?
Symptom relief Recruiting nowThe purpose of this study is to examine two early interventions, Written Exposure Therapy and Capnometry Guided Breathing, to reduce post-traumatic stress disorder (PTSD) symptoms in women after childbirth as compared to usual care.
Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New study tests if personalized cholesterol targets beat standard statins for seniors with diabetes
Disease control Recruiting nowStatins are the cornerstone of cardiovascular disease (CVD) prevention through the lowering of low-density lipoprotein cholesterol (LDL-C). While the benefits of intensive LDL-C lowering are well-established for secondary prevention, evidence remains insufficient for primary prev…
Sponsor: Sin Gon Kim • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug aims to slow kidney disease in IgA nephropathy patients
Disease control Recruiting nowThis study is a randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate the efficacy and safety of SHR-2173 in patients with Primary IgA Nephropathy(IgAN). The study consists of a screening period, a run-in period, a 48-week double-blind treatment period,…
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug pirtobrutinib tested for Long-Term safety in blood cancers
Disease control Recruiting nowThis study will evaluate the long-term safety of pirtobrutinib in participants with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study is open to those who completed J2N-MC-JZNN/LOXO-BTK-20020 (NCT 04666038) for continued access t…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New strategy aims to cut unneeded prostate biopsies in half
Diagnosis Recruiting nowProstate cancer diagnosis based on systematic or MRI-targeted biopsy is associated with substantial overdiagnosis and unnecessary invasive procedures. Although multiparametric MRI improves detection of clinically significant prostate cancer, optimal criteria for biopsy omission-p…
Sponsor: In Gab Jeong, MD • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Could the gut hold the key to calming autoinflammatory Flare-Ups?
Knowledge-focused Recruiting nowAutoinflammatory diseases (AID) are genetic diseases responsible for excessive activation of innate immunity leading to blood inflammation and systemic symptoms. Most patients display digestive involvements that may resemble inflammatory bowel disease. Several studies have found …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can stem cells restore hearing? early trial aims to find out
Disease control By invitation onlyThe HEAR-RESTORE study is an exploratory clinical research program designed to evaluate new diagnostic and regenerative approaches for individuals experiencing inner ear injury, tinnitus, and temporary or permanent hearing loss. Inner ear disorders can result from acoustic trauma…
Early phase 1 • Sponsor: Truway Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New brain zaps could lift depression in days
Symptom relief Recruiting nowMajor depressive disorder (MDD) is a common and disabling psychiatric condition, and many patients do not achieve adequate response to standard antidepressant treatments. Accelerated intermittent theta burst stimulation (iTBS) is a promising neuromodulation approach that may prov…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC